AGP Executive Report
Last update: 11 hours agoPTSD Treatment Breakthrough: A new Nature Medicine study reports FDA-approved synthetic THC (dronabinol) can reduce the frequency and intensity of PTSD nightmares, pointing to a clearer medical role for cannabinoid drugs in sleep and symptom relief. Hemp Ban Fight: The White House-backed push to delay a federal ban on intoxicating hemp products is colliding with a fast-moving government funding bill, with GOP senators vowing to kill the hemp delay measure over kids’ access concerns. Regulatory Access in New York: New York law expands where licensed cannabis microbusinesses can sell, allowing participation in “Cannabis Showcase Events” at approved farmers markets and pop-ups—aimed at boosting smaller operators. Courtroom Cannabis Reality Checks: Ontario’s review board cut a hospital reporting schedule for a man found not criminally responsible twice, while noting cannabis use as a “potent risk factor” tied to his past offenses. Public Safety & Enforcement: Michigan confirmed a fast-spreading invasive “mile-a-minute” weed near a prior detection site, while drug enforcement headlines included a major cannabis trafficking conviction in Malaysia and ongoing anti-drug operations in Pahang.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
